Coincidence of antibodies against Hwp1 and ASCA, two distinct molecular targets of Candida albicans, reinforces the link between this fungal species and coeliac disease

Boualem Sendid,Christopher Cao,Jean-Frederic Colombel,Daniel Poulain,Boualem SendidChristopher CaoJean-Frederic ColombelDaniel Poulaina CNRS,UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle,Univ INSERM U1285,Lille,Franceb CHU Lille,Laboratoire de Parasitologie-Mycologie,Lille,Francec Dr Henry D Janowitz Division of Gastroenterology,Icahn School of Medicine,Mount Sinai Hospital,New York,USA
DOI: https://doi.org/10.1080/21505594.2024.2334085
IF: 5.428
2024-03-27
Virulence
Abstract:Candida albicans is an immunogen for anti- Saccharomyces cerevisiae antibodies (ASCA), a serological marker of Crohn's disease. ASCA has also been reported in other autoimmune diseases, including coeliac disease (CeD). A strong antibody response against Hwp1, a protein associated with invasive hyphal form of C. albicans which presents peptide sequence homologies with gliadin, has also been described in CeD. This observation supports the hypothesis that C. albicans hyphal transition in C. albicans may trigger CeD onset through a mechanism of molecular/antigenic mimicry. In this study, we assessed whether the anti- C. albicans oligomannose and anti-Hwp1 protein responses may be linked despite their different pathophysiological significance. The measurement of ASCA levels in a cohort of patients involved in our previous Hwp1 study showed a significant correlation between the two biomarkers. This new observation further reinforces the link between C. albicans and CeD.
microbiology,immunology,infectious diseases
What problem does this paper attempt to address?